Xalatan(R) Receives Paediatric Indication In Europe

Links shared publicly online about this topic.

  • 783
    total visits

Xalatan(R) Receives Paediatric Indication In Europe

medicalnewstoday.com —

Pfizer announced that Xalatan 0.005% (latanoprost) has been approved by the European Commission for reduction of elevated intraocular pressure (IOP) in the treatment of paediatric patients with el

View full resource at medicalnewstoday.com

Tags: Glaucoma Medication, Intraocular Pressure Medication, Xalatan, Xalacom, Pfizer

  • Share

Most Recently Shared on October 22, 2010 at 8:05 pm By:

mnt_pediatrics MNT Pediatrics News

Xalatan(R) Receives Paediatric Indication In Europe http://mnt.to/3LBb #pediatrics

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

medical_tweets medical_tweets

MNT Eye Health MNT Eye Health

Advertisement